GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OraSure Technologies Inc (FRA:EP3) » Definitions » Institutional Ownership

OraSure Technologies (FRA:EP3) Institutional Ownership : 56.63% (As of Sep. 25, 2024)


View and export this data going back to . Start your Free Trial

What is OraSure Technologies Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, OraSure Technologies's institutional ownership is 56.63%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, OraSure Technologies's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, OraSure Technologies's Float Percentage Of Total Shares Outstanding is 79.57%.


OraSure Technologies Institutional Ownership Historical Data

The historical data trend for OraSure Technologies's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OraSure Technologies Institutional Ownership Chart

OraSure Technologies Historical Data

The historical data trend for OraSure Technologies can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 56.45 56.72 54.21 54.86 56.83 58.92 60.22 56.94 55.61 56.63

OraSure Technologies Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


OraSure Technologies Business Description

Traded in Other Exchanges
Address
220 East First Street, Bethlehem, PA, USA, 18015
OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.

OraSure Technologies Headlines

No Headlines